← Back to Clinical Trials
Recruiting NCT06649500

NCT06649500 Identify the Most Effective Rehabilitation Method Between a Treatment with a Sensorized Treadmill (Walker View) and a Treatment with Conventional Group Therapy in Balance Disorders and the Use of Artificial Intelligence to Identify Predictive Indices to Prevent Falls and Diagnose Promptly the Risk

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06649500
Status Recruiting
Phase
Sponsor Fondazione Policlinico Universitario Campus Bio-Medico
Condition Balance Disorders
Study Type INTERVENTIONAL
Enrollment 108 participants
Start Date 2024-12-04
Primary Completion 2026-05

Trial Parameters

Condition Balance Disorders
Sponsor Fondazione Policlinico Universitario Campus Bio-Medico
Study Type INTERVENTIONAL
Phase N/A
Enrollment 108
Sex ALL
Min Age 65 Years
Max Age N/A
Start Date 2024-12-04
Completion 2026-05
Interventions
Treadmillconventional therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Falls in the elderly are one of the main sources of disability and hospitalization, with a significant impact on quality of life and social and healthcare costs. Falls represent a significant health concern for people over 60 years old. Numerous studies have shown that falls cause serious health consequences. Around 30% of people over the age of 60 experience a fall during the year. According to the impact falls have, the investigators decided to analyze the effectiveness of training on a Walker View sensorized treadmill, with the possibility of exercises for coordination and balance, compared to training with a conventional group therapy, in order to understand the best training to reduce the risk of falling and observe the possible improvements in daily life activities. So the study aims to identify the most effective rehabilitation method between a treatment with a sensorized treadmill (Walker View) and a conventional group therapy in balance disorders. The study also aims to identify predictive indices, with the use of Artificial Intelligence, that can contribute to the prevention and diagnosis of balance disorders in a short time and prevent falls in the elderly.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 65 years * Consent to participate in the study * Positive history of balance disorders * Absence of cognitive deficits (MMSE ≥ 24) * Tinetti \< 25 Exclusion Criteria: * Clinical pictures associated with musculoskeletal, cardiovascular, cerebrovascular, neuro-psychic problems and post-surgical outcomes that make the planned evaluation tests unfeasible. * Inability to carry out a walking test. * History of more than one fall in the last six months. * Subjects who have not expressed informed consent to participate in the study.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology